BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6102376)

  • 1. [Interaction between clonidine and alpha-blockers (author's transl)].
    Huchet AM; Chelly J; Schmitt H
    Nouv Presse Med; 1980 Feb; 9(9):613-4. PubMed ID: 6102376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic study of several alpha-adrenolytics].
    Mouillé P; Dabiré H; Andrejak M; Schmitt H
    C R Seances Acad Sci D; 1980 Jun; 290(24):1553-5. PubMed ID: 6105928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
    Roquebert J; Demichel P; Malek A; Canellas J
    J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs.
    Delini-Stula A
    Pol J Pharmacol Pharm; 1984; 36(5):513-21. PubMed ID: 6152494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N; Hofferber E
    Arzneimittelforschung; 1980; 30(12):2135-9. PubMed ID: 6111325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study.
    Marwaha J; Aghajanian GK
    J Pharmacol Exp Ther; 1982 Aug; 222(2):287-93. PubMed ID: 6124632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
    Shepperson NB; Duval N; Massingham R; Langer SZ
    J Pharmacol Exp Ther; 1981 Nov; 219(2):540-6. PubMed ID: 6270312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by mianserin and classical alpha-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine.
    Robson RD; Antonaccio MJ; Saelens JK; Liebman J
    Eur J Pharmacol; 1978 Feb; 47(4):431-42. PubMed ID: 24544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral postsynaptic alpha-adrenoceptor blocking properties of some new dihydrobenzofurane and imidazoline derivatives in pithed rats.
    Mouillé P; Dabiré H; Joly G; Schmitt H
    Arzneimittelforschung; 1984; 34(12):1749-52. PubMed ID: 6152168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors.
    Jiménez-Mena LR; Gupta S; Muñoz-Islas E; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Aug; 543(1-3):68-76. PubMed ID: 16814767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adrenergic antagonists on clonidine-induced inhibition of basal gastric secretion in conscious rats.
    Bugajski J; Hano J; Lech J
    Pol J Pharmacol Pharm; 1980; 32(4):593-604. PubMed ID: 6114484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-adrenoceptor antagonist (blocker)].
    Shigetomi S
    Nihon Rinsho; 1997 Aug; 55(8):2055-60. PubMed ID: 9284423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effect of clonidine on mesenteric artery adrenoceptors: agonistic (alpha-2) and antagonistic (alpha-1).
    Silva EG; Feres T; Vianna LM; Okuyama P; Paiva TB
    J Pharmacol Exp Ther; 1996 May; 277(2):872-6. PubMed ID: 8627569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
    Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
    J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology and clinical application of alpha-blocking drugs (author's transl)].
    Weber S; Merillon JP; Motte G; Gourgon R
    Therapie; 1980; 35(6):665-76. PubMed ID: 6112802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.